Ripretinib for advanced gastrointestinal stromal tumours – Authors’ reply - 02/09/20
Doi : 10.1016/S1470-2045(20)30479-4
Jean-Yves Blay a, b, c, d 
, Margaret von Mehren e
, Margaret von Mehren e a Department of Medical Oncology, Centre Léon Bérard, 69008 Lyon, France
b Unicancer, Paris, France
c Lyon Research Innovation for Cancer, Lyon, France
d Université Claude Bernard, Lyon, France
e Department of Hematology and Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA
El texto completo de este artículo está disponible en PDF.
© 2020
Elsevier Ltd. Reservados todos los derechos.
Vol 21 - N° 9
P. e415 - septembre 2020 Regresar al número
Artículo precedente
- Ripretinib for advanced gastrointestinal stromal tumours
- Tim J A Dekker
- Head and neck surgery recommendations during the COVID-19 pandemic
- Thomas J Galloway, Luiz Paulo Kowalski, Leandro L Matos, Gilberto Castro Junior, John A Ridge
¿Ya suscrito a @@106933@@ revista ?